Mitchell Kapoor Analyst PerformanceBiotech Analyst at HC WainwrightMitchell Kapoor is a stock analyst at HC Wainwright focused in the medical sector, covering 29 publicly traded companies. Over the past year, Mitchell Kapoor has issued 21 stock ratings, including buy and hold recommendations. While full access to Mitchell Kapoor's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mitchell Kapoor's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings70 Last 1 YearsBuy Recommendations88.41% 61 Buy RatingsCompanies Covered29 Unique Companies Ratings Distribution69RatingsDistribution of strong buy, buy, hold, and sell ratings by Mitchell Kapoor.RatingPercentageCount Strong Buy0.0%0 ratings Buy88.4%61 ratings Hold11.6%8 ratings Sell0.0%0 ratingsOut of 69 total stock ratings issued by Mitchell Kapoor at HC Wainwright, the majority (88.4%) have been Buy recommendations, followed by 11.6% Hold.Best & Worst CallsBest Call0000.0%ALMSApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%RNACJan 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ96.6% of companies on NASDAQ28 companiesNYSE3.4% of companies on NYSE1 companyMitchell Kapoor, an analyst at HC Wainwright, currently covers 29 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical28 companies96.6%Manufacturing1 company3.4%Mitchell Kapoor of HC Wainwright specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE17 companies58.6%MED - DRUGS10 companies34.5%Miscellaneous1 company3.4%PHARMACEUTICAL PREPARATIONS1 company3.4% Mitchell Kapoor's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsEVMNEvommune1/6/2026Initiated Coverage$16.07$35.00Buy$0.0000.00% ROIMGTXMeiraGTx11/24/2025Initiated Coverage$7.46$20.00Buy$0.0000.00% ROIMGTXMeiraGTx11/24/2025Initiated Coverage$7.57$20.00Buy$0.0000.00% ROINTLAIntellia Therapeutics10/30/2025Set Price Target$12.52$18.00$0.0000.00% ROICRSPCRISPR Therapeutics8/7/2025Boost Price Target$56.34$80.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics8/6/2025Boost Price Target$60.81$75.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals7/31/2025Reiterated Rating$43.37$65.00Buy$0.0000.00% ROIALMSAlumis7/25/2025Reiterated Rating$3.86$14.00Buy$0.0000.00% ROIKRROKorro Bio7/24/2025Reiterated Rating$16.85$100.00Buy$0.0000.00% ROIORKAOruka Therapeutics7/23/2025Reiterated Rating$14.06$45.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. LEGNLegend Biotech7/17/2025Reiterated Rating$39.75$75.00Buy$0.0000.00% ROILEGNLegend Biotech7/8/2025Reiterated Rating$35.87$75.00Buy$0.0000.00% ROITYRATyra Biosciences7/1/2025Reiterated Rating$9.57$30.00Buy$0.0000.00% ROISMMTSummit Therapeutics7/1/2025Reiterated Rating$21.28$44.00Buy$0.0000.00% ROILYELLyell Immunopharma6/24/2025Reiterated Rating$8.99$10.00Neutral$0.0000.00% ROIVERVVerve Therapeutics6/18/2025Downgrade$11.38$13.50Neutral$0.0000.00% ROITILInstil Bio6/5/2025Reiterated Rating$34.40$125.00Buy$0.0000.00% ROIBOLDBoundless Bio6/2/2025Initiated Coverage$1.10$5.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics6/2/2025Upgrade$3.95$15.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics5/29/2025Reiterated Rating$54.43$72.00Buy$0.0000.00% ROIKYTXKyverna Therapeutics5/27/2025Upgrade$2.27$5.00Buy$0.0000.00% ROITILInstil Bio5/22/2025Lower Price Target$16.22$105.00Buy$0.0000.00% ROILXEOLexeo Therapeutics5/16/2025Lower Price Target$2.70$15.00Buy$0.0000.00% ROICTMXCytomX Therapeutics5/15/2025Upgrade$2.38$5.00Buy$0.0000.00% ROINGNENeurogene5/13/2025Lower Price Target$17.70$45.00Buy$00.0000.00% ROIKRROKorro Bio5/8/2025Lower Price Target$13.84$100.00Buy$00.0000.00% ROIALMSAlumis4/30/2025Reiterated Rating$4.33$14.00Buy$00.0000.00% ROIEDITEditas Medicine4/28/2025Initiated Coverage$1.54$3.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics4/25/2025Reiterated Rating$59.25$72.00Buy$00.0000.00% ROILEGNLegend Biotech4/16/2025Reiterated Rating$33.74$75.00Buy$00.0000.00% ROILYELLyell Immunopharma4/16/2025Reiterated Rating$9.18$20.00Neutral$00.0000.00% ROIVERVVerve Therapeutics4/14/2025Boost Price Target$4.05$25.00Buy$0.0000.00% ROIRNACCartesian Therapeutics4/9/2025Reiterated Rating$9.52$40.00Buy$0.0000.00% ROIRLYBRallybio4/9/2025Reiterated Rating$0.25Neutral$0.0000.00% ROILXEOLexeo Therapeutics4/8/2025Reiterated Rating$1.79$23.00Buy$0.0000.00% ROILEGNLegend Biotech4/8/2025Reiterated Rating$30.25$75.00Buy$00.0000.00% ROIIONSIonis Pharmaceuticals4/7/2025Initiated Coverage$27.09$45.00Buy$00.0000.00% ROIKYTXKyverna Therapeutics4/3/2025Lower Price Target$2.15$4.00Neutral$0.0000.00% ROIMGXMetagenomi4/3/2025Lower Price Target$1.33$7.00Buy$0.0000.00% ROIZURAZura Bio4/3/2025Lower Price Target$1.17$3.00Neutral$0.0000.00% ROIThe SpaceX filing is public. The window is closing. (Ad)SpaceX just filed its S-1. The IPO is confirmed for June 12 - $75 billion, ticker SPCX, potentially the largest in history. The 21-bank syndicate has already locked up shares, so retail investors won't get access. But the S-1 exposed one publicly traded company Musk cannot operate without - and it's still cheap. Dylan Jovine is releasing the ticker free before June 12 changes the price.Get the ticker before the SpaceX IPO reprices everything on June 12IPSCCentury Therapeutics4/3/2025Lower Price Target$0.47$2.00Buy$0.0000.00% ROIRANIRani Therapeutics4/3/2025Reiterated Rating$1.39$9.00Buy$0.0000.00% ROITYRATyra Biosciences3/31/2025Reiterated Rating$9.77$30.00Buy$00.0000.00% ROILXEOLexeo Therapeutics3/26/2025Reiterated Rating$4.44$23.00Buy$0.0000.00% ROINGNENeurogene3/25/2025Lower Price Target$13.96$50.00Buy$00.0000.00% ROIVERVVerve Therapeutics3/25/2025Reiterated Rating$5.78$15.00Buy$0.0000.00% ROIABEOAbeona Therapeutics3/24/2025Reiterated Rating$5.15$15.00Buy$0.0000.00% ROIKRROKorro Bio3/20/2025Reiterated Rating$23.72$115.00Buy$00.0000.00% ROIRLYBRallybio3/17/2025Reiterated Rating$5.06$40.00Buy$0.0000.00% ROIRNACCartesian Therapeutics3/14/2025Lower Price Target$16.61$40.00Buy$0.0000.00% ROILYELLyell Immunopharma3/13/2025Reiterated Rating$13.43$20.00Neutral$00.0000.00% ROILEGNLegend Biotech3/12/2025Boost Price Target$37.19$75.00Buy$00.0000.00% ROICTMXCytomX Therapeutics3/7/2025Reiterated Rating$0.62Neutral$0.0000.00% ROIHALOHalozyme Therapeutics3/6/2025Reiterated Rating$59.53Buy$00.0000.00% ROINTLAIntellia Therapeutics3/5/2025Initiated Coverage$9.10$30.00Buy$00.0000.00% ROITILInstil Bio3/5/2025Reiterated Rating$17.50$110.00Buy$0.0000.00% ROIVERVVerve Therapeutics2/28/2025Boost Price Target$6.20$15.00Buy$0.0000.00% ROISMMTSummit Therapeutics2/25/2025Reiterated Rating$18.84$44.00Buy$00.0000.00% ROIABEOAbeona Therapeutics2/19/2025Reiterated Rating$5.85$15.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics2/19/2025Boost Price Target$57.90$72.00Buy$00.0000.00% ROITYRATyra Biosciences2/18/2025Reiterated Rating$13.19$30.00Buy$00.0000.00% ROIRLYBRallybio2/12/2025Reiterated Rating$5.97$40.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics2/4/2025Reiterated Rating$56.28$70.00Buy$00.0000.00% ROICRSPCRISPR Therapeutics2/3/2025Initiated Coverage$41.59$65.00Buy$00.0000.00% ROIRNACCartesian Therapeutics1/28/2025Reiterated Rating$19.42$45.00Buy$0.0000.00% ROIIPSCCentury Therapeutics1/22/2025Reiterated Rating$0.90$5.00Buy$0.0000.00% ROILEGNLegend Biotech1/21/2025Reiterated Rating$32.66$73.00Buy$00.0000.00% ROIRLYBRallybio1/13/2025Reiterated Rating$7.52$40.00Buy$0.0000.00% ROITYRATyra Biosciences1/13/2025Reiterated Rating$15.20$30.00Buy$00.0000.00% ROIHALOHalozyme Therapeutics1/10/2025Boost Price Target$53.76$70.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenJefferies Financial GroupWeiss RatingsUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.The Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
